Back

Mendelian randomization unravels bidirectional effects of NAFLD and heart failure across subtypes

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Striving for effective heart failure therapies Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Mr Shengkang Huang

Beijing (China)

4 More presentations in this session

Presentation thumbnail
Survival benefits of SGLT2 inhibitors in very elderly patients with heart failure with preserved ejection fraction
Doctor Y. Ge (Beijing, CN)
Abstract Slides
Presentation thumbnail
Classification and regression tree analysis for identification of long-term risk in patients with heart failure with preserved ejection fraction. final results of the Argentine ARFEY-Preser Registry
Doctor E. Perna (Corrientes, AR)
Abstract Slides
Presentation thumbnail
Association between resting heart rate and clinical outcomes in heart failure with preserved ejection fraction: age stratified insights from the KUNIUMI Registry
Mr T. Matsuura (Kobe, JP)
Abstract Slides
Presentation thumbnail
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: a Bayesian network meta-analysis of randomized controlled trials
Doctor I. Zahan (Harefield, GB)
Abstract Slides

Access the full session

Session thumbnail
Striving for effective heart failure therapies

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Absence of causal association between NAFLD and heart failure: mendelian randomization evidence"
30 August 2025
thumbnail
Congress Presentation
Association between diabetes mellitus and abdominal aortic aneurysm: a mendelian randomization study
3 September 2019
thumbnail
Congress Presentation
Antihypertensive drugs in experimental NAFLD as the first step to the establishment of criteria for choosing appropriate treatment of hypertension in NAFLD carriers
2 September 2019
thumbnail
Congress Presentation
Significant link between subclinical left ventricular systolic dysfunction and non-alcoholic fatty liver disease in metabolic syndrome patients
1 July 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources